Control of cell proliferation and differentiation in breast and prostate cancer [ 2003 - 2008 ]

Research Grant

Researchers: Prof Rob Sutherland (Principal investigator) ,  Prof Christopher Ormandy ,  Prof Elizabeth Musgrove ,  Prof Roger Daly

Brief description Breast and prostate cancer are the most commonly diagnosed cancers in women and men respectively, together accounting for >25% of all newly diagnosed cancers in Australia and other developed countries. Although significant improvements in the management of these cancers have occurred in the past 20 years further research is needed to better understand the molecular mechanisms of disease development and progression. Such research is critical to the better management and ultimate control of these diseases through better treatments and prevention. A multidisciplinary team of cancer researchers at the Garvan Institute of Medical Research, with a 10 year track record of discovery and application of their research into breast and prostate cancer, will employ state-of-the-art research tools to identify new molecules and molecular pathways involved in these diseases. This new information will facilitate the improved management of these cancers through improved assessment of disease progression at the time of diagnosis and the development of new drugs and strategies for treatment and prevention.

Funding Amount $AUD 5,043,011.64

Funding Scheme Programs

Notes Program Grant